NEW research underway in the US is exploring the possibility that diabetes drug metformin could also contribute to a longer life.
Deputy scientific director of the American Federation for Aging Research (AFAR) Dr Nir Barzilai said his research found some genetic variants that appeared to confer protection against ageing diseases.
For more than 60 years metformin has been used as a very cheap first-line treatment for diabetes.
Now, trials in a variety of animals have shown they also live healthier, longer lives with the mechanism uncertain, but linked to reduction of oxidative damage and inflammation in cells.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 17
